MPLT – maplight therapeutics, inc. (US:NASDAQ)
Stock Stats
News
MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress
Maplight Therapeutics (NASDAQ:MPLT) was upgraded by analysts at Jefferies Financial Group Inc. to a "strong-buy" rating.
Maplight Therapeutics (NASDAQ:MPLT) was upgraded by analysts at Zacks Research to a "hold" rating.
Maplight Therapeutics (NASDAQ:MPLT) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Maplight Therapeutics (NASDAQ:MPLT) was downgraded by analysts at Wall S
Form 10-Q MapLight Therapeutics, For: Sep 30
Form 8-K MapLight Therapeutics, For: Dec 04
Form SCHEDULE 13D MapLight Therapeutics, Filed by: Catalyst4, Inc.
Form 3/A MapLight Therapeutics, For: Oct 25 Filed by: Pavlov George
Form SCHEDULE 13D MapLight Therapeutics, Filed by: Novo Holdings A/S
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.